Pheochromocytoma

35,105views

Pheochromocytoma

Watch later

Watch later

Inflammation
Wound healing
Shock: Clinical
Type II hypersensitivity
Type I hypersensitivity
Type IV hypersensitivity
Type III hypersensitivity
Cystic fibrosis
Muscular dystrophy
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Respiratory alkalosis
Metabolic alkalosis
Hypoxia
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Ischemia
Free radicals and cellular injury
Myocardial infarction
Hypertension
Cushing syndrome
Pheochromocytoma
Coarctation of the aorta
Hypotension
Chronic venous insufficiency
Deep vein thrombosis
Shock
Tetralogy of Fallot
Persistent truncus arteriosus
Ventricular septal defect
Atrial septal defect
Patent ductus arteriosus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Aortic valve disease
Pulmonary valve disease
Tricuspid valve disease
Mitral valve disease
Cor pulmonale
Heart failure
Endocarditis
Myocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Atrioventricular block
Bundle branch block
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Premature atrial contraction
Atrial flutter
Atrial fibrillation
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Coronary artery disease: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Cardiomyopathies: Pathology review
Supraventricular arrhythmias: Pathology review
Heart failure: Pathology review
Valvular heart disease: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Pericardial disease: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Endocarditis: Pathology review
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Hypercalcemia
Hypoparathyroidism
Hypocalcemia
Diabetes mellitus
Diabetic nephropathy
Hypopituitarism
Hyperpituitarism
Diabetes insipidus
Hyperthyroidism: Pathology review
Adrenal insufficiency: Pathology review
Hypothyroidism: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Hypopituitarism: Pathology review
Diabetic retinopathy
Peptic ulcer
Ulcerative colitis
Crohn disease
Bowel obstruction
Gallstone ileus
Abdominal hernias
Inguinal hernia
Small bowel ischemia and infarction
Diverticulosis and diverticulitis
Appendicitis
Jaundice
Cirrhosis
Portal hypertension
Gallstones
Acute cholecystitis
Chronic cholecystitis
Acute pancreatitis
Chronic pancreatitis
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Pathology review
Esophageal disorders: Pathology review
Diverticular disease: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Cirrhosis: Pathology review
Iron deficiency anemia
Sideroblastic anemia
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Megaloblastic anemia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Polycythemia vera (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Leukemias: Pathology review
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
DiGeorge syndrome
Hereditary angioedema
Complement deficiency
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Osteoporosis
Spina bifida
Intracerebral hemorrhage
Subarachnoid hemorrhage
Epidural hematoma
Subdural hematoma
Alzheimer disease
Parkinson disease
Hypermagnesemia
Hyperkalemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypernatremia
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Alport syndrome
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Chronic kidney disease
Renal artery stenosis
Nephritic syndromes: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Acute respiratory distress syndrome
Asthma
Emphysema
Chronic bronchitis
Bronchiectasis
Restrictive lung diseases
Sarcoidosis
Pneumonia
Pneumothorax
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Respiratory distress syndrome: Pathology review
Pneumonia: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review

Transcript

Watch video only

In pheochromocytoma, pheo- means dark, chromo- refers to color, cyto- refers to a cell and -oma means tumor. So a pheochromocytoma is a rare adrenal gland tumor where the cells darken when they form tumors.

Now, there are two adrenal glands, one above each kidney, and each one has an outer layer called the cortex and an inner layer called the medulla.

In the medulla, there are cells called chromaffin cells and their job is to make hormones called catecholamines. The catecholamines include epinephrine and norepinephrine - the fight or flight hormones.

Normally, the chromaffin cells in the adrenal gland secrete epinephrine and norepinephrine into the blood when something scary happens - like someone saying BOOM!

The epinephrine and norepinephrine bind to alpha and beta receptors in various tissues throughout our body and cause an increase in cardiac output, increased blood pressure, dilated pupils, increased blood flow to skeletal muscles, and increased blood sugar.

Pheochromocytomas are tumors that form when these chromaffin cells start to divide uncontrollably.

They typically form in one of the adrenal glands, but rarely can be in both and sometimes can even develop in other parts of the body where chromaffin cells are found like the carotid arteries in the neck, the bladder, and the abdominal aorta.

Most pheochromocytomas arise sporadically, but some are associated with an inherited syndrome.

One of these is multiple endocrine neoplasias type 2A and type 2B, where pheochromocytoma is caused by a mutation in the RET gene, which is a protooncogene that encodes for proteins that promote cell growth and division.

When the RET gene mutates, it becomes an oncogene that causes the cells to divide constantly.

Another disease associated with pheochromocytomas is Von Hippel-Lindau disease, which develops when there’s a mutation in the VHL gene which codes for the von Hippel-Lindau tumor suppressor protein.

Tumor suppressor proteins normally inhibit cell growth and division and mutations result in uncontrolled cell proliferation leading to tumors.

A third disease is neurofibromatosis type 1, which is caused by a mutation in the gene NF1 that encodes for another tumor suppressor protein called neurofibromin, and the mechanism here is similar to Von Hippel-Lindau disease.

Once pheochromocytomas develop, they cause problems by releasing too many catecholamines into the blood. The catecholamine release is unregulated and could happen continuously or at random times.

However certain things like stress, physical exertion, or even certain foods that contain the molecule tyramine like chocolate, cheese, and wine can trigger the release of catecholamines.

Imagine getting stressed, and then going to the gym, and then indulging in a plate of chocolate and cheese washed down with a glass of wine - a recipe for triggering catecholamine release!

Key Takeaways

A pheochromocytoma is a neuroendocrine tumor of chromaffin cells in the adrenal medulla. Pheochromocytomas cause problems by producing too much of the catecholamines epinephrine and norepinephrine, which then causes sympathetic nervous system hyperactivity, resulting in symptoms like high blood pressure, headaches, palpitations, and sweating.

Pheochromocytomas are diagnosed by testing the urine for catecholamines and metanephrine; and imaging studies such as CT or MRI. Treatment involves surgical removal of the tumor, and medications to control blood pressure and heart rate.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?" Annals of Surgical Oncology (2007)
  7. "Multiple endocrine neoplasia type 2: An overview" Genetics in Medicine (2011)